{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:11:36Z","timestamp":1767993096867,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00059-020-04899-y","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T16:40:58Z","timestamp":1584463258000},"page":"233-242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hypertrophe Kardiomyopathie","Hypertrophic cardiomyopathy"],"prefix":"10.1007","volume":"45","author":[{"given":"Angelika","family":"Batzner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert","family":"Seggewi\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"key":"4899_CR1","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu199","volume":"35","author":"PM Elliott","year":"2014","unstructured":"Elliott\u00a0PM, Anastasakis\u00a0A et\u00a0al (2014) 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart\u00a0J 35:2733\u20132779","journal-title":"Eur Heart J"},{"key":"4899_CR2","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","volume":"92","author":"BJ Maron","year":"1995","unstructured":"Maron\u00a0BJ, Gardin\u00a0JM, Flack\u00a0JM et\u00a0al (1995) Prevalence of hypertrophic cardiomyopathy in a\u00a0general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 92:785\u2013789","journal-title":"Circulation"},{"key":"4899_CR3","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","volume":"65","author":"C Semsarian","year":"2015","unstructured":"Semsarian\u00a0C, Ingles\u00a0J, Maron\u00a0MS, Maron\u00a0BJ (2015) New perspectives on the prevalence of hypertrophic cardiomyopathy. J\u00a0Am Coll Cardiol 65:1249\u20131254","journal-title":"J Am Coll Cardiol"},{"key":"4899_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/hrt.20.1.1","volume":"20","author":"D Teare","year":"1958","unstructured":"Teare\u00a0D (1958) Asymmetrical hypertrophy of the heart in young adults. Br Heart\u00a0J 20:1\u20138","journal-title":"Br Heart J"},{"key":"4899_CR5","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1161\/01.CIR.85.5.1651","volume":"85","author":"HG Klues","year":"1992","unstructured":"Klues\u00a0HG, Maron\u00a0BJ, Dollar\u00a0AL, Roberts\u00a0WC (1992) Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation 85:1651\u20131660","journal-title":"Circulation"},{"key":"4899_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1056\/NEJMoa021332","volume":"348","author":"MS Maron","year":"2003","unstructured":"Maron\u00a0MS, Olivotto\u00a0I, Betocchi\u00a0S et\u00a0al (2003) Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N\u00a0Engl J Med 348:295\u2013303","journal-title":"N Engl J Med"},{"key":"4899_CR7","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","volume":"114","author":"MS Maron","year":"2006","unstructured":"Maron\u00a0MS, Olivotto\u00a0I, Zenovich\u00a0AG et\u00a0al (2006) Hypertrophic cardiomyopathy is predominantly a\u00a0disease of left ventricular outflow tract obstruction. Circulation 114:2232\u20132239","journal-title":"Circulation"},{"key":"4899_CR8","volume-title":"Charakteristik von Patienten mit Hypertropher Kardiomyopathie: Eine vergleichende Analyse an drei Referenzzentren","author":"A Neugebauer","year":"2011","unstructured":"Neugebauer\u00a0A (2011) Charakteristik von Patienten mit Hypertropher Kardiomyopathie: Eine vergleichende Analyse an drei Referenzzentren. Promotionsarbeit an der Ruhr-Universit\u00e4t, Bochum"},{"key":"4899_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1161\/01.CIR.40.1.3","volume":"40","author":"PM Shah","year":"1969","unstructured":"Shah\u00a0PM, Gramiak\u00a0R, Kramer\u00a0DH (1969) Ultrasound localization of left ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy. Circulation 40:3\u201311","journal-title":"Circulation"},{"key":"4899_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.pcad.2006.08.001","volume":"49","author":"MV Sherrid","year":"2006","unstructured":"Sherrid\u00a0MV (2006) Pathophysiology and treatment of hypertrophic cardiomyopathy. Prog Cardiovasc Dis 49:123\u2013151","journal-title":"Prog Cardiovasc Dis"},{"key":"4899_CR11","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/0002-9149(65)90378-4","volume":"15","author":"ED Wigle","year":"1965","unstructured":"Wigle\u00a0ED, David\u00a0PR, Labroose\u00a0CJ, McMeekan\u00a0J (1965) Muscular subaortic stenosis; the interrelation of wall tension, outflow tract \u201cdistending pressure\u201d and orifice radius. Am J Cardiol 15:761\u2013772","journal-title":"Am J Cardiol"},{"key":"4899_CR12","first-page":"187","volume":"59","author":"A Koljaja-Batzner","year":"2018","unstructured":"Koljaja-Batzner\u00a0A, Pfeiffer\u00a0B, Seggewiss\u00a0H (2018) Die hypertrophe Kardiomyopathie \u2013 h\u00e4ufig und nicht erkannt. Internist Prax 59:187\u2013201","journal-title":"Internist Prax"},{"key":"4899_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s00399-018-0567-x","volume":"29","author":"H Seggewiss","year":"2018","unstructured":"Seggewiss\u00a0H, Koljaja-Batzner\u00a0A, Seggewiss\u00a0K, Meesmann\u00a0M (2018) Synkope bei hypertropher (obstruktiver) Kardiomyopathie. Herzschrittmacherther Elektrophysiol 29:178\u2013182","journal-title":"Herzschrittmacherther Elektrophysiol"},{"key":"4899_CR14","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","volume":"35","author":"C O\u2019Mahony","year":"2014","unstructured":"O\u2019Mahony\u00a0C, Jichi\u00a0F, Pavlou\u00a0M et al (2014) A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart\u00a0J 35:2010\u20132020","journal-title":"Eur Heart J"},{"key":"4899_CR15","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/j.1540-8175.2008.00688.x","volume":"25","author":"T Hecker","year":"2008","unstructured":"Hecker\u00a0T, De Pasquale\u00a0CG, Perry\u00a0R et al (2008) Side effects of high-dose dobutamine are not prevented by normal saline infusion in dobutamine stress echocardiography. Echocardiography 25:712\u2013716","journal-title":"Echocardiography"},{"key":"4899_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000073045","volume":"100","author":"MA Losi","year":"2003","unstructured":"Losi\u00a0MA, Betocchi\u00a0S, Aversa\u00a0M et\u00a0al (2003) Dobutamine stress echocardiography in hypertrophic cardiomyopathy. Cardiology 100:93\u2013100","journal-title":"Cardiology"},{"key":"4899_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0002-9149(01)01640-X","volume":"88","author":"AM Varnava","year":"2001","unstructured":"Varnava\u00a0AM, Elliott\u00a0PM, Mahon\u00a0N et\u00a0al (2001) Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol 88:275\u2013279","journal-title":"Am J Cardiol"},{"key":"4899_CR18","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","volume":"121","author":"AJ Marian","year":"2017","unstructured":"Marian\u00a0AJ, Braunwald\u00a0E (2017) Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res 121:749\u2013770","journal-title":"Circ Res"},{"key":"4899_CR19","doi-asserted-by":"publisher","first-page":"388","DOI":"10.21037\/cdt.2019.02.01","volume":"9","author":"CM Wolf","year":"2019","unstructured":"Wolf\u00a0CM (2019) Hypertrophic cardiomyopathy: genetics and clinical perspectives. Cardiovasc Diagn Ther 9:388\u2013415","journal-title":"Cardiovasc Diagn Ther"},{"key":"4899_CR20","doi-asserted-by":"publisher","first-page":"e2194","DOI":"10.4244\/EIJ-D-15-00159","volume":"12","author":"RM Cooper","year":"2017","unstructured":"Cooper\u00a0RM, Binukrishnan\u00a0SR, Shahzad\u00a0A et\u00a0al (2017) Computed tomography angiography planning identifies the target vessel for optimum infarct location and improves clinical outcome in alcohol septal ablation for hypertrophic obstructive cardiomyopathy. EuroIntervention 12:e2194\u2013e2203","journal-title":"EuroIntervention"},{"key":"4899_CR21","first-page":"623","volume":"105","author":"C O\u2019Mahony","year":"2019","unstructured":"O\u2019Mahony\u00a0C, Akhtar\u00a0MM, Anastasiou\u00a0Z et al (2019) Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: a\u00a0systematic review and meta-analysis. Heart 105:623\u2013631","journal-title":"Heart"},{"key":"4899_CR22","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1161\/CIRCHEARTFAILURE.112.969626","volume":"5","author":"AF Schinkel","year":"2012","unstructured":"Schinkel\u00a0AF, Vriesendorp\u00a0PA, Sijbrands\u00a0EJ et al (2012) Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis. Circ Heart Fail 5:552\u2013559","journal-title":"Circ Heart Fail"},{"key":"4899_CR23","first-page":"47","volume":"116","author":"A Batzner","year":"2019","unstructured":"Batzner\u00a0A, Schafers\u00a0HJ, Borisov\u00a0KV, Seggewiss\u00a0H (2019) Hypertrophic obstructive cardiomyopathy. Dtsch Arztebl Int 116:47\u201353","journal-title":"Dtsch Arztebl Int"},{"key":"4899_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ijcard.2006.04.080","volume":"117","author":"F Cabrera-Bueno","year":"2007","unstructured":"Cabrera-Bueno\u00a0F, Garcia-Pinilla\u00a0JM, Gomez-Doblas\u00a0JJ et al (2007) Beta-blocker therapy for dynamic left ventricular outflow tract obstruction induced by exercise. Int J Cardiol 117:222\u2013226","journal-title":"Int J Cardiol"},{"key":"4899_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1136\/hrt.42.1.35","volume":"42","author":"M Kaltenbach","year":"1979","unstructured":"Kaltenbach\u00a0M, Hopf\u00a0R, Kober\u00a0G et\u00a0al (1979) Treatment of hypertrophic obstructive cardiomyopathy with verapamil. Br Heart\u00a0J 42:35\u201342","journal-title":"Br Heart J"},{"key":"4899_CR26","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/01.CIR.64.3.437","volume":"64","author":"SE Epstein","year":"1981","unstructured":"Epstein\u00a0SE, Rosing\u00a0DR (1981) Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy. Circulation 64:437\u2013441","journal-title":"Circulation"},{"key":"4899_CR27","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.jacc.2005.01.012","volume":"45","author":"MV Sherrid","year":"2005","unstructured":"Sherrid\u00a0MV, Barac\u00a0I, McKenna\u00a0WJ et\u00a0al (2005) Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. J\u00a0Am Coll Cardiol 45:1251\u20131258","journal-title":"J Am Coll Cardiol"},{"key":"4899_CR28","doi-asserted-by":"publisher","first-page":"741","DOI":"10.7326\/M18-3016","volume":"170","author":"SB Heitner","year":"2019","unstructured":"Heitner\u00a0SB, Jacoby\u00a0D, Lester\u00a0SJ et\u00a0al (2019) Mavacamten treatment for obstructive hypertrophic cardiomyopathy: a clinical trial. Ann Intern Med 170:741\u2013748","journal-title":"Ann Intern Med"},{"key":"4899_CR29","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1161\/CIRCRESAHA.116.309348","volume":"121","author":"RA Nishimura","year":"2017","unstructured":"Nishimura\u00a0RA, Seggewiss\u00a0H, Schaff\u00a0HV (2017) Hypertrophic obstructive cardiomyopathy: surgical myectomy and septal ablation. Circ Res 121:771\u2013783","journal-title":"Circ Res"},{"key":"4899_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0140-6736(95)91267-3","volume":"346","author":"U Sigwart","year":"1995","unstructured":"Sigwart\u00a0U (1995) Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 346:211\u2013214","journal-title":"Lancet"},{"key":"4899_CR31","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1161\/01.CIR.98.22.2415","volume":"98","author":"L Faber","year":"1998","unstructured":"Faber\u00a0L, Seggewiss\u00a0H, Gleichmann\u00a0U (1998) Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. Circulation 98:2415\u20132421","journal-title":"Circulation"},{"key":"4899_CR32","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1001\/jamacardio.2016.0252","volume":"1","author":"LK Kim","year":"2016","unstructured":"Kim\u00a0LK, Swaminathan\u00a0RV, Looser\u00a0P et\u00a0al (2016) Hospital volume outcomes after septal myectomy and alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: US nationwide inpatient database, 2003\u20132011. JAMA Cardiol 1:324\u2013332","journal-title":"JAMA Cardiol"},{"key":"4899_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/00000658-196108000-00003","volume":"154","author":"AG Morrow","year":"1961","unstructured":"Morrow\u00a0AG, Brockenbrough\u00a0EC (1961) Surgical treatment of idiopathic hypertrophic subaortic stenosis: technic and hemodynamic results of subaortic ventriculomyotomy. Ann Surg 154:181\u2013189","journal-title":"Ann Surg"},{"key":"4899_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jtcvs.2010.08.011","volume":"142","author":"EA Ashikhmina","year":"2011","unstructured":"Ashikhmina\u00a0EA, Schaff\u00a0HV, Ommen\u00a0SR et\u00a0al (2011) Intraoperative direct measurement of left ventricular outflow tract gradients to guide surgical myectomy for hypertrophic cardiomyopathy. J\u00a0Thorac Cardiovasc Surg 142:53\u201359","journal-title":"J Thorac Cardiovasc Surg"},{"key":"4899_CR35","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.amjcard.2013.01.340","volume":"111","author":"EJ Rowin","year":"2013","unstructured":"Rowin\u00a0EJ, Maron\u00a0BJ, Lesser\u00a0JR et\u00a0al (2013) Papillary muscle insertion directly into the anterior mitral leaflet in hypertrophic cardiomyopathy, its identification and cause of outflow obstruction by cardiac magnetic resonance imaging, and its surgical management. Am J Cardiol 111:1677\u20131679","journal-title":"Am J Cardiol"},{"key":"4899_CR36","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.amjcard.2013.02.040","volume":"111","author":"KW Klarich","year":"2013","unstructured":"Klarich\u00a0KW, Attenhofer Jost\u00a0CH, Binder\u00a0J et al (2013) Risk of death in long-term follow-up of patients with apical hypertrophic cardiomyopathy. Am J Cardiol 111:1784\u20131791","journal-title":"Am J Cardiol"},{"key":"4899_CR37","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.jacc.2015.06.1333","volume":"66","author":"BJ Maron","year":"2015","unstructured":"Maron\u00a0BJ, Dearani\u00a0JA, Ommen\u00a0SR et\u00a0al (2015) Low operative mortality achieved with surgical septal myectomy: role of dedicated hypertrophic cardiomyopathy centers in the management of dynamic Subaortic obstruction. J\u00a0Am Coll Cardiol 66:1307\u20131308","journal-title":"J Am Coll Cardiol"},{"key":"4899_CR38","first-page":"I191","volume":"80","author":"R Mohr","year":"1989","unstructured":"Mohr\u00a0R, Schaff\u00a0HV, Puga\u00a0FJ, Danielson\u00a0GK (1989) Results of operation for hypertrophic obstructive cardiomyopathy in children and adults less than 40 years of age. Circulation 80:I191\u2013I196","journal-title":"Circulation"},{"key":"4899_CR39","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/ejcts\/ezx398","volume":"53","author":"A Nguyen","year":"2018","unstructured":"Nguyen\u00a0A, Schaff\u00a0HV, Nishimura\u00a0RA et\u00a0al (2018) Does septal thickness influence outcome of myectomy for hypertrophic obstructive cardiomyopathy? Eur J Cardiothorac Surg 53:582\u2013589","journal-title":"Eur J Cardiothorac Surg"},{"key":"4899_CR40","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.jtcvs.2015.07.063","volume":"150","author":"MY Desai","year":"2015","unstructured":"Desai\u00a0MY, Smedira\u00a0NG, Bhonsale\u00a0A et\u00a0al (2015) Symptom assessment and exercise impairment in surgical decision making in hypertrophic obstructive cardiomyopathy: relationship to outcomes. J\u00a0Thorac Cardiovasc Surg 150:928\u2013935e1","journal-title":"J Thorac Cardiovasc Surg"},{"key":"4899_CR41","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1016\/j.jacc.2011.08.040","volume":"58","author":"W Ball","year":"2011","unstructured":"Ball\u00a0W, Ivanov\u00a0J, Rakowski\u00a0H et al (2011) Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment. J\u00a0Am Coll Cardiol 58:2313\u20132321","journal-title":"J Am Coll Cardiol"},{"key":"4899_CR42","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1093\/eurheartj\/ehm117","volume":"28","author":"CJ McLeod","year":"2007","unstructured":"McLeod\u00a0CJ, Ommen\u00a0SR, Ackerman\u00a0MJ et\u00a0al (2007) Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy. Eur Heart\u00a0J 28:2583\u20132588","journal-title":"Eur Heart J"},{"key":"4899_CR43","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1016\/j.jacc.2018.09.064","volume":"72","author":"A Batzner","year":"2018","unstructured":"Batzner\u00a0A, Pfeiffer\u00a0B, Neugebauer\u00a0A et\u00a0al (2018) Survival after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. J\u00a0Am Coll Cardiol 72:3087\u20133094","journal-title":"J Am Coll Cardiol"},{"key":"4899_CR44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00392-003-0878-7","volume":"92","author":"L Faber","year":"2003","unstructured":"Faber\u00a0L, Seggewiss\u00a0H, Welge\u00a0D et\u00a0al (2003) Predicting the risk of atrioventricular conduction lesions after percutaneous septal ablation for obstructive hypertrophic cardiomyopathy. Z\u00a0Kardiol 92:39\u201347","journal-title":"Z Kardiol"},{"key":"4899_CR45","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1161\/01.CIR.101.15.1764","volume":"101","author":"J Schulz-Menger","year":"2000","unstructured":"Schulz-Menger\u00a0J, Strohm\u00a0O, Waigand\u00a0J, Uhlich\u00a0F et al (2000) The value of magnetic resonance imaging of the left ventricular outflow tract in patients with hypertrophic obstructive cardiomyopathy after septal artery embolization. Circulation 101:1764\u20131766","journal-title":"Circulation"},{"key":"4899_CR46","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s00392-005-0256-8","volume":"94","author":"L Faber","year":"2005","unstructured":"Faber\u00a0L, Seggewiss\u00a0H, Gietzen\u00a0FH et al (2005) Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the TASH-registry of the German Cardiac Society. Z\u00a0Kardiol 94:516\u2013523","journal-title":"Z Kardiol"},{"key":"4899_CR47","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s00392-007-0578-9","volume":"96","author":"L Faber","year":"2007","unstructured":"Faber\u00a0L, Welge\u00a0D, Fassbender\u00a0D et al (2007) One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response. Clin Res Cardiol 96:864\u2013873","journal-title":"Clin Res Cardiol"},{"key":"4899_CR48","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1055\/s-2008-1043055","volume":"121","author":"U Gleichmann","year":"1996","unstructured":"Gleichmann\u00a0U, Seggewiss\u00a0H, Faber\u00a0L et\u00a0al (1996) Catheter treatment of hypertrophic obstructive cardiomyopathy. Dtsch Med Wochenschr 121:679\u2013685","journal-title":"Dtsch Med Wochenschr"},{"key":"4899_CR49","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1007\/s00392-007-0579-8","volume":"96","author":"H Seggewiss","year":"2007","unstructured":"Seggewiss\u00a0H, Rigopoulos\u00a0A, Welge\u00a0D et al (2007) Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Clin Res Cardiol 96:856\u2013863","journal-title":"Clin Res Cardiol"},{"key":"4899_CR50","doi-asserted-by":"publisher","first-page":"e005735","DOI":"10.1161\/JAHA.117.005735","volume":"6","author":"J Veselka","year":"2017","unstructured":"Veselka\u00a0J, Faber\u00a0L, Liebregts\u00a0M et al (2017) Outcome of alcohol septal ablation in mildly symptomatic patients with hypertrophic obstructive cardiomyopathy: a long-term follow-up study based on the Euro-alcohol septal ablation registry. J\u00a0Am Heart Assoc 6:e5735","journal-title":"J Am Heart Assoc"},{"key":"4899_CR51","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1053\/euhj.1999.1520","volume":"20","author":"FH Gietzen","year":"1999","unstructured":"Gietzen\u00a0FH, Leuner\u00a0CJ, Raute-Kreinsen\u00a0U et al (1999) Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy. Eur Heart\u00a0J 20:1342\u20131354","journal-title":"Eur Heart J"},{"key":"4899_CR52","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.jcin.2017.03.030","volume":"10","author":"M Liebregts","year":"2017","unstructured":"Liebregts\u00a0M, Faber\u00a0L, Jensen\u00a0MK et\u00a0al (2017) Outcomes of alcohol septal ablation in younger patients with obstructive hypertrophic cardiomyopathy. JACC Cardiovasc Interv 10:1134\u20131143","journal-title":"JACC Cardiovasc Interv"},{"key":"4899_CR53","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jacc.2007.05.018","volume":"50","author":"I Olivotto","year":"2007","unstructured":"Olivotto\u00a0I, Ommen\u00a0SR, Maron\u00a0MS et\u00a0al (2007) Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a\u00a0randomized trial? J\u00a0Am Coll Cardiol 50:831\u2013834","journal-title":"J Am Coll Cardiol"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-020-04899-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-020-04899-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-020-04899-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T01:00:29Z","timestamp":1615942829000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-020-04899-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["4899"],"URL":"https:\/\/doi.org\/10.1007\/s00059-020-04899-y","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"assertion":[{"value":"17 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0Batzner und H.\u00a0Seggewi\u00df geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}